[Plasmapheresis in the treatment of myasthenia gravis].
D003131:Combined Modality Therapy; D003366:Cosyntropin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000628:therapy*; D010956:Plasmapheresis / Q000009:adverse effects; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D003366:Cosyntropin; D011729:Pyridostigmine Bromide; D008775:Methylprednisolone
Plasmaféresis en el tratamiento de la miastenia gravis.